• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Outcomes of Root Enlargement Versus Root Replacement for Aortic Stenosis
CONCLUSIONS: ARE and stentless xenograft ARR for aortic stenosis were associated with comparable postoperative complications, aortic valve reinterventions, freedom from readmission, and 5-year survival.PMID:36584836 | DOI:10.1016/j.athoracsur.2022.12.027
Source: The Annals of Thoracic Surgery - December 30, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Sarah Yousef Derek Serna-Gallegos James A Brown Takuya Ogami Yisi Wang Floyd W Thoma Danny Chu Johannes Bonatti David Kaczorowski Pyongsoo Yoon Ibrahim Sultan Source Type: research

Cardiac Operations after Transcatheter Aortic Valve Replacement
CONCLUSIONS: Cardiac operations after TAVR are increasing and interval between TAVR and operation decreasing. Most cardiac operations are complex, high-risk reoperations and isolated AVR rare. These findings should be considered when TAVR is selected for low-intermediate risk patients, particularly with multiple cardiac pathologies not addressed by TAVR.PMID:34800488 | DOI:10.1016/j.athoracsur.2021.10.022
Source: The Annals of Thoracic Surgery - November 20, 2021 Category: Cardiovascular & Thoracic Surgery Authors: James Yun Osama Abou Saleh Jin Woo Chung Faisal G Bakaeen Shinya Unai Michael Z Tong Eric E Roselli Douglas R Johnston Edward G Soltesz Jeevanantham Rajeswaran Samir Kapadia Eugene H Blackstone G östa B Pettersson A Marc Gillinov Lars G Svensson Source Type: research

One-year outcomes of the pivotal clinical trial of a balloon-expandable transcatheter aortic valve implantation in Japanese dialysis patients
CONCLUSIONS: TAVR using SAPIEN 3 is safe and effective for the treatment of Japanese dialysis patients with symptomatic severe aortic valve stenosis.PMID:34348863 | DOI:10.1016/j.jjcc.2021.07.006
Source: Journal of Cardiology - August 5, 2021 Category: Cardiology Authors: Koichi Maeda Toru Kuratani Isamu Mizote Kentaro Hayashida Hikaru Tsuruta Tatsuo Takahashi Keiichi Fukuda Hideyuki Shimizu Yasushi Sakata Yoshiki Sawa Source Type: research

Short- and long-term outcomes in dialysis patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis
ConclusionDialysis patients had significantly higher rates of short- and long-term mortality, short-term life threatening and/or major bleeding, permanent pacemaker implantation, and device failure compared to non-dialysis patients. Careful patient selection who would benefit from TAVI in patients with ESRD requiring dialysis, is necessary to prevent high-rates of post-procedural complications.
Source: Canadian Journal of Cardiology - January 25, 2020 Category: Cardiology Source Type: research

Predictors of Cumulative Health Care Costs Associated with Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis
ConclusionsThis analysis shows that there are 3 distinct phases of cost accumulation from referral to post-TAVR with some potentially modifiable cost drivers in each phase.
Source: Canadian Journal of Cardiology - December 18, 2019 Category: Cardiology Source Type: research

In ‐hospital outcomes of transcatheter versus surgical aortic valve replacement in non‐teaching hospitals
ConclusionsTAVR conferred similar in ‐hospital mortality and major peri‐procedural complications compared with SAVR in non‐teaching hospitals. For those with limited access to teaching hospitals, non‐teaching hospitals appear to be a reasonable option for candidates of aortic valve replacement for severe aortic stenosis.
Source: Catheterization and Cardiovascular Interventions - November 8, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Tomo Ando, Oluwole Adegbala, Pedro A. Villablanca, Alexandros Briasoulis, Hisato Takagi, Cindy L. Grines, Theodore Schreiber, Tamim Nazif, Susheel Kodali, Luis Afonso Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease
ConclusionsECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation.
Source: The Annals of Thoracic Surgery - September 18, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease.
CONCLUSIONS: ECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation. PMID: 30236527 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - September 17, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Watkins AC, Maassel NL, Ghoreishi M, Dawood MY, Pham SM, Kon ZN, Taylor BS, Griffith BP, Gammie JS Tags: Ann Thorac Surg Source Type: research

Pages: 1  2  3